SEC Form 4 · accession 0001179110-16-022590
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vipin K Garg
Officer — Chief Executive Officer · Director
Period of report
Apr 1, 2016
Accepted (ET)
Apr 1, 2016 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.74 | Apr 1, 2016 | A | 100,000 | A | — | Apr 1, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017. 75,000 shares underlying this stock option vest in four equal, annual installments beginning on April 1, 2017, provided that certain performance-based metrics have been met or satisfied on or before September 30, 2016.